Cutaneous melanoma management — Update and narrative review for the General Surgeon
Background and Aims:
The multidisciplinary management of cutaneous melanoma is advancing rapidly. Surgeons remain a key entry point for melanoma patients into specialist care and their up-to-date knowledge is vital for patient outcomes.
Methods:
A narrative review was performed to provide an update for the surgeon working outside of a high-volume melanoma
centre.
Results:
This review covers recent developments in the management of both localised and metastatic cutaneous melanoma and
how immunotherapy is changing the melanoma landscape.
Conclusion:
This review offers a review of the literature and perspectives on potential future developments in cutaneous melanoma management from the Melanoma Institute of Australia.
Source:
Das, N., Dhamija, R., Kaelber, D. C., Kelly, M., Xie, P., & Reddy, D. (2025). Adverse neurologic events of immune checkpoint inhibitor monotherapy vs. combination therapy for melanoma. Neuro-Oncology Advances, 7(1). https://doi.org/10.1093/noajnl/vdaf030